Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer
Pituitary, 10/29/09
Guerra Y et al. – The authors report the case of a 60 year old male who complained of headache and blurry vision—that progressed to left ophthalmoplegia and ptosis—after receiving a dose of leuprolide for Prostate cancer therapy. Imaging showed a hemorrhagic sellar mass. Particular attention to clinical findings suggestive of a non functioning pituitary tumor in patients receiving GnRH agonist therapy is critical as routine screening with MRI is not practical.
Related Articles
Signalling Pathway Alterations in Pituitary Adenomas: Involvement of Gsalpha, cAMP and Mitogen-Activated Protein Kinases
Journal of Neuroendocrinology, 11/03/09
Relevance Score: 68%
Regulation of Pituitary Function by Cytokines
Hormone Research, 10/27/09
Relevance Score: 67%
Pituitary metastasis of Merkel cell carcinoma
Journal of Neuro-Oncology, 10/28/09
Relevance Score: 66%
Predicting Recurrence of Nonfunctioning Pituitary Adenomas
Journal of Clinical Endocrinology and Metabolism, 10/15/09
Relevance Score: 66%
The natural history of surgically treated but radiotherapy-naive nonfunctioning pituitary adenomas
Clinical Endocrinology, 10/15/09
Relevance Score: 65%
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines
Neuroendocrinology, 11/24/09
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


